Nef and Vpu protect infected cells from ADCP mediated by plasma from people with HIV-1
mBio · 09.09.2026 · 17 (9)
DOI: 10.1128/mbio.01487-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, erschienen am 09.09.2026. Verfasst von Étienne Bélanger und 15 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche du CHUM, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: HIV-1, Human Immunodeficiency Virus Proteins, Viral Regulatory and Accessory Proteins, HIV Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
The HIV-1 envelope glycoprotein (Env) represents the only viral antigen at the surface of infected cells, making it an ideal target for antibody-based therapies. Most antibodies elicited in people with HIV (PWH) do not recognize Env in its native “closed” conformation but readily bind to Env when it samples the CD4-bound “open” conformation. Downregulation of CD4 at the surface of infected cells by the viral accessory proteins Nef and Vpu prevents the premature opening of Env and has been shown to protect infected cells from antibody-dependent cellular cytotoxicity (ADCC) mediated by PWH plasma. Here, we report that deletion of Nef and Vpu from primary infectious molecular clones renders infected cells vulnerable to antibody-dependent cellular phagocytosis (ADCP) mediated by PWH plasma. This is in part linked to the premature engagement of Env with CD4. In agreement with an “open” Env being vulnerable to ADCP, small CD4-mimetic compounds (CD4mc) sensitize in vitro -infected cells and ex vivo -expanded CD4 T cells to ADCP mediated by autologous monocytes in the presence of PWH plasma. This effect was further improved by increasing cell surface Env through IFN-induced BST-2 upregulation. IMPORTANCE Developing new therapies to eliminate HIV-1-infected cells is essential to decrease the size of the HIV-1 reservoir. Fc-effector functions, such as antibody-dependent cellular cytotoxicity (ADCC), have shown potential in eliminating in vitro- infected cells and ex vivo- expanded infected cells from people with HIV, decreasing the size of the reservoir, and delaying viral rebound in humanized mice. Here, we report that antibody-dependent cellular phagocytosis (ADCP) can also be harnessed to eliminate HIV-1-infected cells. We show that infected cells harboring “open” Env conformations are susceptible to ADCP-mediated killing in the presence of plasma from people with HIV. A better understanding of the contribution of different Fc-effector functions in the elimination of infected cells could help guide the development of new therapeutic approaches toward an HIV-1 cure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre de Recherche du CHUM, Montreal, Quebec, Canada.
- Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada.
- Centre Armand-Frappier Santé Biotechnologie, Institut national de la recherche scientifique, Laval, Quebec, Canada.
- Infectious Diseases Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
- Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
- Department of Chemistry, School of Arts and Sciences, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Jonathan Richard, Simona Stäger, Marzena Pazgier, Andrés Finzi
Förderung
- NIAID NIH HHS
Zitieren
APA
Bélanger, É., Tauzin, A., Tajebe, F., Chandravanshi, M., Yang, D., Chen, H. C., Chiu, T. J., Bourassa, C., Medjahed, H., Tolbert, W. D., Durand, M., Richard, J., Huryn, D. M., Stäger, S., Pazgier, M., & Finzi, A. (2026). Nef and Vpu protect infected cells from ADCP mediated by plasma from people with HIV-1. mBio, 17(9). https://doi.org/10.1128/mbio.01487-26
Vancouver
Bélanger É, Tauzin A, Tajebe F, Chandravanshi M, Yang D, Chen HC, et al. Nef and Vpu protect infected cells from ADCP mediated by plasma from people with HIV-1. mBio. 2026;17(9). doi:10.1128/mbio.01487-26
BibTeX
@article{Blanger2026,
author = {Bélanger, Étienne and Tauzin, Alexandra and Tajebe, Fitsumbrhan and Chandravanshi, Monika and Yang, Derek and Chen, Hung-Ching and Chiu, Ta-Jung and Bourassa, Catherine and Medjahed, Halima and Tolbert, William D and Durand, Madeleine and Richard, Jonathan and Huryn, Donna M and Stäger, Simona and Pazgier, Marzena and Finzi, Andrés},
title = {Nef and Vpu protect infected cells from ADCP mediated by plasma from people with HIV-1},
journal = {mBio},
year = {2026},
volume = {17},
number = {9},
doi = {10.1128/mbio.01487-26}
}
EUVIMED